Serum HBV DNA suppression and seroconversion following long-term adefovir dipivoxil therapy in chronic hepatitis B patients.

被引：0
|
作者：
Heathcote, EJ
Jeffers, L
Perrillo, R
Wright, T
Sherman, M
Gilson, R
Shakil, AO
Namini, H
James, C
Ho, V
Fry, J
Brosgart, CL
机构：
[1] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[2] Univ Miami, Miami, FL 33152 USA
[3] Ochsner Clin N 8, New Orleans, LA USA
[4] San Francisco VA Med Ctr, San Francisco, CA USA
[5] Toronto Gen Hosp, Toronto, ON, Canada
[6] Mortimer Market Ctr, London, England
[7] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[8] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
575
引用
收藏
页码：316A / 316A
页数：1
相关论文
共 50 条
  • [21] HBsAg seroconversion in adefovir dipivoxil (ADV) treated chronic hepatitis B (CHB) patients
    Shiffman, M
    Marcellin, P
    Jeffers, L
    Gordon, S
    Peters, M
    Rizzetto, M
    Buggisch, P
    Vetter, D
    Choy, GS
    Westland, C
    Arterburn, S
    Currie, G
    Brosgart, CL
    JOURNAL OF HEPATOLOGY, 2004, 40 : 17 - 17
  • [22] Long-term outcome of chronic hepatitis B patients initially treated with adefovir dipivoxil in a community practice
    Ha, Nghiem
    Ha, Nghi
    Garcia, Ruel
    Trinh, Huy
    Nguyen, Huy
    Nguyen, Khanh
    Levitt, Brian
    Nguyen, Nghia
    Nguyen, Mindie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S151 - S152
  • [23] Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B A meta-analysis
    Luo, Qing
    Deng, Yong
    Cheng, Feifei
    Kang, Juan
    Zhong, Shan
    Zhang, Dazhi
    Zeng, Weiqiong
    MEDICINE, 2016, 95 (50) : e5578
  • [24] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B patients with various baseline biochemical levels: Results from 4 years adefovir dipivoxil treatment
    Zhuang, L.
    You, J.
    Kong, L.
    Li, Y. L.
    Lei, H.
    Ma, Y. L.
    Chen, H. Y.
    Liu, H. E.
    Feng, X.
    Ma, S. J.
    Huang, J. H.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    Yan, S. M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 319 - 319
  • [25] Long-term incidence of adefovir dipivoxil (ADV) resistance in chronic hepatitis B (CHB) patients after 144 weeks of therapy
    Qi, X
    Snow, A
    Thibault, V
    Zhu, Y
    Curtis, M
    Hadziyannis, SJ
    Brosgart, CL
    Currie, G
    Arterburn, S
    Gibbs, CS
    Miller, MD
    Xiong, S
    JOURNAL OF HEPATOLOGY, 2004, 40 : 20 - 21
  • [26] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
    Hadziyannis, Stephanos J.
    Tassopoulos, Nicolaos C.
    Heathcote, E. Jenny
    Chang, Ting-Tsung
    Kitis, George
    Rizzetto, Mario
    Marcellin, Patrick
    Lik, Seng Gee
    Goodman, Zachary
    Ma, Jia
    Brosgart, Carol L.
    Eorroto-Esoda, Katyna
    Arterburn, Sarah
    Chuck, Steven L.
    GASTROENTEROLOGY, 2006, 131 (06) : 1743 - 1751
  • [27] Combination of telbivudine and adefovir dipivoxil therapy in chronic hepatitis B patients with poor response to adefovir dipivoxil monotherapy
    Chen, E. -Q.
    Zhou, T. -Y.
    Tang, H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S18 - S18
  • [28] Long-term adefovir dipivoxil (ADV) demonstrates sustained efficacy in chronic hepatitis B (CHB)
    Brosgart, CL
    Hadziyannis, S
    Benhamou, Y
    Arterburn, S
    Ma, J
    Lu, B
    Xiong, S
    Wollman, M
    James, C
    Chang, CG
    Currie, G
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A47 - A48
  • [29] DURABILITY OF ADEFOVIR DIPIVOXIL INDUCED HBEAG LOSS FOLLOWING LONG-TERM ADDITIONAL THERAPY IN PATIENTS WITH YMDD MUTANTS OF HEPATITIS B VIRUS
    Kim, Sung Eun
    Chung, Young-Hwa
    Kim, Jeong A.
    Lee, Yoon-Seon
    Lee, Danbi
    Lee, Sae Hwan
    Seo, Dong Dae
    Shin, Jung Woo
    Park, Neung Hwo
    Kim, Kang Mo
    Lee, Han Chu
    Lee, Yung Sang
    Suh, Dong Jin
    HEPATOLOGY, 2008, 48 (04) : 704A - 704A
  • [30] Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B
    Toyama, Takashi
    Ishida, Hisashi
    Ishibashi, Hiromi
    Yatsuhashi, Hiroshi
    Nakamuta, Makoto
    Shimada, Masaaki
    Ohta, Hajime
    Satoh, Takeaki
    Kato, Michio
    Hijioka, Taizo
    Takano, Hirotsugu
    Komeda, Toshiki
    Yagura, Michiyasu
    Mano, Hiroshi
    Watanabe, Yukio
    Kobayashi, Masakazu
    Mita, Eiji
    HEPATOLOGY RESEARCH, 2012, 42 (12) : 1168 - 1174
12345